Combined effects of 17-DMAG and TNF on cells through a mechanism related to the NF-kappaB pathway

Diagnostic Pathology

Volumn 8, Issue 1, 2013, Pages

  Qu, Zhuling ^a   Dong, He ^a   Xu, Xiaolin ^a   Feng, Wei ^a   Yi, Xuanlong ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

17 DMAG; IKK ; NF B Pathway; TNF

Indexed keywords

17-(DIMETHYLAMINOETHYLAMINO)-17-DEMETHOXYGELDANAMYCIN; ALVESPIMYCIN; ANTINEOPLASTIC AGENT; BENZOQUINONE DERIVATIVE; HEAT SHOCK PROTEIN 90; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROCYCLIC LACTAM; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL SURVIVAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BENZOQUINONES; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP90 HEAT-SHOCK PROTEINS; HUMANS; I-KAPPA B KINASE; LACTAMS, MACROCYCLIC; LUNG NEOPLASMS; NF-KAPPA B; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876784930     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-8-70     Document Type: Article

References (35)

1. Prodromou C, Roe SM, O'Brien R, Ladbury JE, Piper PW, Pearl LH. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 1997, 90:65-75. 10.1016/S0092-8674(00)80314-1, 9230303.
2. da Silva VC, Ramos CH. The network interaction of the human cytosolic 90 kDa heat shock protein Hsp90: A target for cancer therapeutics. J Proteomics 2012, 75:2790-2802. 10.1016/j.jprot.2011.12.028, 22236519.
3. Taipale M, Jarosz DF, Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 2010, 11:515-528. 10.1038/nrm2918, 20531426.
4. Theodoraki MA, Caplan AJ. Quality control and fate determination of Hsp90 client proteins. Biochim Biophys Acta 1823, 2012:683-688.
5. Holzbeierlein JM, Windsperger A, Vielhauer G. Hsp90: a drug target?. Curr Oncol Rep 2010, 12:95-101. 10.1007/s11912-010-0086-3, 20425593.
6. Pacey S, Banerji U, Judson I, Workman P. Hsp90 inhibitors in the clinic. Handb Exp Pharmacol 2006, 172:331-358. 10.1007/3-540-29717-0_14, 16610366.
7. Neckers L, Ivy SP. Heat shock protein 90. Curr Opin Oncol 2003, 15:419-424. 10.1097/00001622-200311000-00003, 14624223.
8. Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 2003, 425:407-410. 10.1038/nature01913, 14508491.
9. Aggarwal BB. Signaling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003, 3:745-756. 10.1038/nri1184, 12949498.
10. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003, 10:45-65. 10.1038/sj.cdd.4401189, 12655295.
11. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-nB signal. Immunity 1998, 8:297-303. 10.1016/S1074-7613(00)80535-X, 9529147.
12. Ting AT, Pimentel-Muinos FX, Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-nB but not Fas/APO-1-initiated apoptosis. EMBO J 1996, 15:6189-6196. 452440, 8947041.
13. Zhang J, Winoto A. A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis. Mol Cell Biol 1996, 16:2756-2763. 231266, 8649383.
14. Karin M, Yamamoto Y, Wang QM. The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov 2004, 3:17-26. 10.1038/nrd1279, 14708018.
15. Yang J, Lin Y, Guo Z. The essential role of MEKK3 in TNF-induced NFκB activation. Nat Immunol 2001, 2:620-624.
16. Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science 1998, 281:998-1001.
17. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS. NFκB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281:1680-1683.
18. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFa induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005, 120:649-661. 10.1016/j.cell.2004.12.041, 15766528.
19. Broemer M, Krappmann D, Scheidereit C. Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation. Oncogene 2004, 23:5378-5386. 10.1038/sj.onc.1207705, 15077173.
20. Lewis J, Devin A, Miller A. Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-κB activation. J Biol Chem 2000, 275:10519-10526. 10.1074/jbc.275.14.10519, 10744744.
21. Fukumoto R, Kiang JG. Geldanamycin analog 17-DMAG limits apoptosis in human peripheral blood cells by inhibition of p53 activation and its interaction with heat-shock protein 90 kDa after exposure to ionizing radiation. Radiat Res 2011, 176:333-345. 10.1667/RR2534.1, 21663398.
22. Lancet JE, Gojo I, Burton M. Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia. Leukemia 2010, 24:699-705. 10.1038/leu.2009.292, 20111068.
23. Jhaveri K, Miller K, Rosen L. A Phase I Dose-Escalation Trial of Trastuzumab and Alvespimycin Hydrochloride (KOS-1022; 17 DMAG) in the Treatment of Advanced Solid Tumors. Clin Cancer Res 2012, Epub ahead of print.
24. Palacios C, Martín-Pérez R, López-Pérez AI, Pandiella A, López-Rivas A. Autophagy inhibition sensitizes multiple myeloma cells to 17-dimethylaminoethylamino-17-demethoxygeldanamycin-induced apoptosis. Leuk Res 2010, 34:1533-1538. 10.1016/j.leukres.2010.07.002, 20667592.
25. Zheng N, Zou P, Wang S, Sun D. In vitro metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in human liver microsomes. Drug Metab Dispos 2011, 39:627-635. 10.1124/dmd.110.036418, 3063720, 21177985.
26. Borkovich KA, Farrelly FW, Finkelstein DB, Taulien J, Lindquist S. Hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures. Mol Cell Biol 1989, 9:3919-3930. 362454, 2674684.
27. Akner G, Mossberg K, Sundqvist KG, Gustafsson JA, Wikstrom AC. Evidence for reversible, non-microtubule and non-microfilament-dependent nuclear translocation of hsp90 after heat shock in human fibroblasts. Eur J Cell Biol 1992, 58:356-364.
28. Biggiogera M, Tanguay RM, Marin R, Wu Y, Martin TE, Fakan S. Localization of heat shock proteins in mouse male germ cells: an immunoelectron microscopical study. Exp Cell Res 1996, 229:77-85. 10.1006/excr.1996.0345, 8940251.
29. Langer T, Rosmus S, Fasold H. Intracellular localization of the 90 kDA heat shock protein (HSP90α) determined by expression of a EGFP-HSP90α-fusion protein in unstressed and heat stressed 3T3 cells. Cell Biol Int 2003, 27:47-52. 10.1016/S1065-6995(02)00256-1, 12713799.
30. Pratt WB, Toft DO. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 1997, 18:306-360. 10.1210/er.18.3.306, 9183567.
31. Pearl LH, Prodromou C. Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem 2006, 75:271-294. 10.1146/annurev.biochem.75.103004.142738, 16756493.
32. Whitesell L, Lindquist SL. HSP90 and the chaperoning of cancer. Nature Rev Cancer 2005, 5:761-772.
33. Keane MM, Rubinstein Y, Cuello M. Inhibition of NF-nB activity enhances TRAIL mediated apoptosis in breast cancer cell lines. Breast Cancer Res Treat 2000, 64:211-219. 10.1023/A:1006458407515, 11194457.
34. Ortiz CM, Ito T, Hashimoto Y, Nagayama S, Iwai A, Tsunoda S. Effects of small interfering RNAs targeting fascin on human esophageal squamous cell carcinoma cell lines. Diagn Pathol 2010, 5:41. 10.1186/1746-1596-5-41, 2907320, 20565981.
35. Lal A, Panos R, Marjanovic M, Walker M, Fuentes E, Kubicek GJ. A gene expression profile test to resolve head & neck squamous versus lung squamous cancers. Diagn Pathol 2013, 8:44. 10.1186/1746-1596-8-44, 3614454, 23497426.